Trial Outcomes & Findings for The Effect of OrthoPulse™ on the Rate of Orthodontic Tooth Movement (NCT NCT02267811)

NCT ID: NCT02267811

Last Updated: 2019-05-21

Results Overview

Rate of participants orthodontic tooth movement using Little's Index of Irregularity (LII) measured in millimeters per week during alignment.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

33 participants

Primary outcome timeframe

Participants will be followed for the duration of their orthodontic treatment, an expected average of 1-2 years, depending on the severity of the case.

Results posted on

2019-05-21

Participant Flow

Participant milestones

Participant milestones
Measure
BX8RN: Orthodontic Treatment With OrthoPulse™ (Treatment)
Subjects assigned to this group receive orthodontic treatment in conjunction with receiving daily OrthoPulse™ treatments. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office. OrthoPulse™: Patients carry out daily OrthoPulse™ treatments at home.
BX8RN: Orthodontic Treatment (Control)
Subjects assigned to this group receive orthodontic treatment without OrthoPulse™ treatment. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office.
Overall Study
STARTED
16
17
Overall Study
COMPLETED
15
15
Overall Study
NOT COMPLETED
1
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The Effect of OrthoPulse™ on the Rate of Orthodontic Tooth Movement

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
BX8RN: OrthoPulse™ (Treatment)
n=16 Participants
Subjects assigned to this group receive orthodontic treatment in conjunction with receiving daily OrthoPulse™ treatments. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office. OrthoPulse™: Patients carry out daily OrthoPulse™ treatments at home.
BX8RN: Orthodontic Treatment With no OrthoPulse™ (Control)
n=17 Participants
Subjects assigned to this group receive orthodontic treatment with no daily OrthoPulse™ treatments. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office.
Total
n=33 Participants
Total of all reporting groups
Age, Categorical
<=18 years
10 Participants
n=99 Participants
9 Participants
n=107 Participants
19 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
n=99 Participants
8 Participants
n=107 Participants
14 Participants
n=206 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Sex: Female, Male
Female
12 Participants
n=99 Participants
6 Participants
n=107 Participants
18 Participants
n=206 Participants
Sex: Female, Male
Male
4 Participants
n=99 Participants
11 Participants
n=107 Participants
15 Participants
n=206 Participants
Region of Enrollment
United States
16 participants
n=99 Participants
17 participants
n=107 Participants
33 participants
n=206 Participants

PRIMARY outcome

Timeframe: Participants will be followed for the duration of their orthodontic treatment, an expected average of 1-2 years, depending on the severity of the case.

Rate of participants orthodontic tooth movement using Little's Index of Irregularity (LII) measured in millimeters per week during alignment.

Outcome measures

Outcome measures
Measure
BX8RN: Orthodontic Treatment With OrthoPulse™ (Treatment)
n=15 Participants
Subjects assigned to this group receive orthodontic treatment in conjunction with receiving daily OrthoPulse™ treatments. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office. OrthoPulse™: Patients carry out daily OrthoPulse™ treatments at home.
BX8RN: Orthodontic Treatment (Control)
n=15 Participants
Subjects assigned to this group receive orthodontic treatment without OrthoPulse™ treatment. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office.
Evaluation of Whether OrthoPulse Use Affects the Rate of Orthodontic Tooth Movement During Full Mouth Fixed Orthodontic Treatment
1.09 millimeters per week
Standard Deviation .68
.39 millimeters per week
Standard Deviation .14

SECONDARY outcome

Timeframe: Participants will be followed for the duration of their orthodontic treatment, an expected average of 1-2 years, depending on the severity of the case.

The number of significant adverse events reported from time of participant enrolment to study completion for all study participants

Outcome measures

Outcome measures
Measure
BX8RN: Orthodontic Treatment With OrthoPulse™ (Treatment)
n=15 Participants
Subjects assigned to this group receive orthodontic treatment in conjunction with receiving daily OrthoPulse™ treatments. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office. OrthoPulse™: Patients carry out daily OrthoPulse™ treatments at home.
BX8RN: Orthodontic Treatment (Control)
n=15 Participants
Subjects assigned to this group receive orthodontic treatment without OrthoPulse™ treatment. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office.
Safety Evidence of OrthoPulse™ Use
0 Adverse Events
0 Adverse Events

SECONDARY outcome

Timeframe: Assessed at six (6) months or later after starting treatment, up to two (2) years.

Population: The overall number of participants is not consistent with the number of participants analyzed in this arm because the panoramic radiographs required to analyze the EARR were not available for the remaining 11 participants.

The amount of EARR experienced as assessed at six (6) months or later after starting treatment. External Apical Root Resorption can result from orthodontic tooth movement. External apical root resorption is the shortening of the root and affects root surface(s), which can result in loss of tooth structure. External apical root resorption is being determined in this study by comparing root lengths from initial to six (6) months or later after starting treatment. The measurements are taken from the crown to the root apex in millimeters. A positive number under the measure of dispersion signifies root resorption.

Outcome measures

Outcome measures
Measure
BX8RN: Orthodontic Treatment With OrthoPulse™ (Treatment)
n=10 Participants
Subjects assigned to this group receive orthodontic treatment in conjunction with receiving daily OrthoPulse™ treatments. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office. OrthoPulse™: Patients carry out daily OrthoPulse™ treatments at home.
BX8RN: Orthodontic Treatment (Control)
n=9 Participants
Subjects assigned to this group receive orthodontic treatment without OrthoPulse™ treatment. Orthodontic Treatment: Patients are treated for orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office.
Degree of External Apical Root Resorption (EARR)
0.02 millimeters
Standard Deviation .86
-0.11 millimeters
Standard Deviation .87

Adverse Events

Fixed Orthodontic Treatment With OrthoPulse™ (Treatment)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Fixed Orthodontic Treatment (Control)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Peter Brawn

Biolux Research, Ltd.

Phone: 6046690674

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place